H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Circadian rhythm of Prolactin concentration following Tumor Necrosis Factor alpha (hrec TNF alpha) infusions in patients with advanced neoplasms

Wojciech Romanowski, Barbara Zubelewicz, Bogumiła Braczkowska, Ryszard Braczkowski

Med Sci Monit 1999; 5(5): CR866-869

ID: 503336


Tumor Necrosis Factor α administered to advanced cancer patients influences either directly or indirectly the endocrine glands and their hormonal secretion. In turn they modulate the biological activity of TNF α. Extensive evidence suggests that TNF α regulates the secretion of T3, T4, cortisol and melatonin. There exists scarce data concerning the effect of TNF α on prolactin levels (PRL) in human beings. The aim of this study was to determine whether TNF α treatment of non-operable cancer patients influenced PRL secretion. The study group comprised 15 patients suffering from colon cancer, who could only receive palliative treatment. Patients were treated with TNF α at a dose of 150 ug/day i.v. for 5 consecutive days (one cycle). Blood was collected several times a day before and following TNF α administration, PRL was measured by means of the RIA method. Results were reported as mean +SE. Single cosine analysis was used to estimate the circadian rhythm. In conclusion, TNF α demonstrated a stimulating effect on PRL secretion. It can probably act by direct activation of pituitary cell PRL receptors or indirectly by the modulation of other cytokines and hormonal secretion, which in turn stimulate PRL release.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree